Pharmacokinetics of Cannabidiol Administered by 3 Delivery Methods at 2 Different Dosages to Healthy Dogs

The purpose of this study was to determine the pharmacokinetics of cannabidiol (CBD) in healthy dogs. Thirty, healthy research dogs were assigned to receive 1 to 3 formulations (oral micoencapsulated oil beads, oral CBD-infused oil, or CBD-infused transdermal cream), at a dose of 75mg or 150mg q12h for 6wk.